Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
Ola ShahinSherif M GoharWalaa IbrahimShirin M El-MakawiWalaa FakherDina Badie TaherMai Abdel SamieMohamed Abd El Fatah KhalilAlia A SalehPublished in: International journal of psychiatry in clinical practice (2022)
It was concluded that plasma BDNF levels in patients with resistant schizophrenia increase after electroconvulsive therapy in association with clinical improvement.Key pointsBDNF increases after ECT treatment of resistant schizophrenia.BDNF is not correlated with the severity of psychotic symptomsPatients treated with ECT showed a better response.
Keyphrases